Antimicrobial activity of inducible human β defensin-2 against Mycoplasma pneumoniae

Current Microbiology

Volumn 52, Issue 6, 2006, Pages 435-438

  Kuwano, Koichi ^a   Tanaka, Noriko ^a   Shimizu, Takashi ^a   Kida, Yutaka ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; INTERLEUKIN 1BETA;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG SQUAMOUS CELL CARCINOMA; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL;

BETA-DEFENSINS; CELLS, CULTURED; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-1; MYCOPLASMA PNEUMONIAE;

BACTERIA (MICROORGANISMS); MYCOPLASMA PNEUMONIAE; MYCOPLASMATALES; POSIBACTERIA;

EID: 33744821633     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-005-0215-7     Document Type: Article

References (24)

1. Arai S, Furukawa M, Munakata T, Kuwano K, Inoue H, Miyazaki T (1990) Enhancement of cytotoxicity of active macrophages by mycoplasma: Role of mycoplasma-associated induction of tumor necrosis factor-alpha (TNF-alpha) in macrophages. Microbiol Immunol 34:231-243
2. Ben-Menachem G, Bystrom T, Rechnitzer H, Rottem S, Rilfors L, Lindblom G (2001) The physico-chemical characteristics of the phosphocholine-containing glycoglycerolipid MfGL-II govern the permeability properties of Mycoplasma fermentans. Eur J Biochem 268:3694-3701
3. Brogden KA (2005) Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-250
4. Faulkner CB, Simecka JW, Davidson MK, Davis JK, Schoeb TR, Lindsey JR, et al. (1995) Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect Immun 63:4084-4090
5. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, et al. (1985) Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 76:1427-1435
6. Gough NM (1988) Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem 173:93-95
7. Hamamoto K, Kida Y, Zhang Y, Shimizu T, Kuwano K (2002) Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol Immunol 46:741-749
8. Hancock RE (1997) Peptide antibiotics. Lancet 349:418-422
9. Hardy RD, Jafri HS, Olsen K, Wordemann M, Hatfield J, Rogers BB, et al. (2001) Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: A microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect Immun 69:3869-3876
10. Jones DE, Bevins CL (1992) Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 267:23216-23225
11. Krause D, Taylor-Robinson D (1992) Mycoplasmas which infect humans. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB (eds) MYCOPLASMAS: molecular biology and pathogenesis. Washington, DC: American Society for Microbiology, pp 417-444
12. Matsuzaki K (1999) Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as arche-types. Biochim Biophys Acta 1462:1-10
13. Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, et al. (2003) Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 71:3730-3739
14. Muhlradt PF, Kiess M, Meyer H, Sussmuth R, Jung G (1997) Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 185:1951-1958
15. Naot Y, Merchav S, Ben-David E, Ginsburg H (1979) Mitogenic activity of Mycoplasma pulmonis. I. Stimulation of rat B and T lymphocytes. Immunology 36:399-406
16. Nishiguchi M, Matsumoto M, Takao T, Hoshino M, Shimonishi Y, Tsuji S, et al. (2001) Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: Role of N-terminal hydrophobic portion in its multiple functions. J Immunol 166:2610-2616
17. Rana FR, Blazyk J (1991) Interactions between the antimicrobial peptide, magainin 2, and Salmonella typhimurium lipopolysaccharides. FEBS Lett 293:11-15
18. Rottem S, Markowitz O (1979) Unusual positional distribution of fatty acids in phosphatidylglycerol of sterol-requiring mycoplasmas. FEBS Lett 107:379-382
19. Scott MG, Gold MR, Hancock RE (1999) Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun 67:6445-6453
20. Shimizu T, Kida Y, Kuwano K (2004) Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors. Immunology 113:121-129
21. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, Greenberg EP, et al. (1998) Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA 95:14961-14966
22. Tsutsumi-Ishii Y, Nagaoka I (2003) Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 170:4226-4236
23. Yang J, Hooper WC, Phillips DJ, Talkington DF (2003) Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific. Microb Pathog 34:17-25
24. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395